1.
Cao R, Du W, Lin B. Comparison and Synergy of iVAC and CRISPR-Related Tumor Immune Strategies: Value Reassessment Under A Zero Genome Risk Reference. IJBLS. 2026;17(2):44-51. doi:10.54097/pnqcf426